EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   2.1.1.356 | Adenocarcinoma of Lung |
28539837 |
Ezh2 Acts as a Tumor Suppressor in Kras-driven Lung Adenocarcinoma. |
causal interaction
therapeutic application
unassigned |
1
3
0 |
| 2.1.1.356 | Biliary Tract Neoplasms |
26254359 |
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer. |
unassigned |
0 |
| 2.1.1.356 | Brain Neoplasms |
19618856 |
[Epigenetic analyses of brain tumor stem cells] |
causal interaction
unassigned |
3
0 |
| 2.1.1.356 | Brain Neoplasms |
34092471 |
Polycomb repressive complex 2 in the driver's seat of childhood and young adult brain tumours. |
unassigned |
0 |
| 2.1.1.356 | Breast Neoplasms |
19243633 |
Gene set-based module discovery in the breast cancer transcriptome. |
causal interaction
unassigned |
1
0 |
| 2.1.1.356 | Breast Neoplasms |
23190500 |
Inhibition of EZH2 suppresses self-renewal and induces radiation sensitivity in atypical rhabdoid teratoid tumor cells. |
causal interaction
diagnostic usage
unassigned |
2
1
0 |
| 2.1.1.356 | Breast Neoplasms |
23539298 |
EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
1
1
0 |
| 2.1.1.356 | Breast Neoplasms |
29207119 |
EZH2 inhibition sensitizes tamoxifen?resistant breast cancer cells through cell cycle regulation. |
causal interaction
therapeutic application
unassigned |
1
1
0 |
| 2.1.1.356 | Breast Neoplasms |
30250895 |
AMPK lifts the PRC2-implemented gene repression. |
ongoing research
unassigned |
2
0 |
| 2.1.1.356 | Breast Neoplasms |
31367244 |
A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
1
3
2
4 |
